GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:23 2024-12-09 am EST			5-day change	1st Jan Change
1,383.00 ^GBX	+2.90%		+3.60%	-4.63%

Dec. 09	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
Dec. 09	Sector Update: Health Care	MT

GSK : Berenberg reaffirms its Buy rating

February 27, 2024 at 08:45 am EST

In a research note, Berenberg analyst Luisa Hector has maintained his recommendation on the stock with a Buy rating. The target price is unchanged at GBX 1820.

Latest news about GSK plc

Sector Update: Health Care Stocks Edge Higher Late Afternoon	Dec. 09	MT
Sector Update: Health Care	Dec. 09	MT
GSK highlights positive Blenrep data from Dreamm-7 trial	Dec. 09	AN
GSK Reports Positive Results in Phase 3 Trial for Refractory Multiple Myeloma Treatment	Dec. 09	MT
GSK Gets Positive Results in Blood-Cancer Drug Trial	Dec. 09	DJ
Global markets live: BlackRock, Apple, Comcast, Boeing, Palantir...	Dec. 09
GSK's Blenrep Combination Therapy for Multiple Myeloma Gets Priority Review in China	Dec. 09	MT
AlphaValue/Baader Europe Lifts CureVac FY24 Outlook	Dec. 09	MT
GSK: applies to the FDA for an expanded indication for Nucala	Dec. 09	CF
GSK: priority review in China for multiple myeloma	Dec. 09	CF
GSK Wins US, Chinese Nod for Regulatory Reviews of Lung Disease, Multiple Myeloma Treatments	Dec. 09	MT
FTSE 100 : London rises, trailing global markets	Dec. 09
GSK's Nucala and Blenrep receive regulatory boost in US and China	Dec. 09	AN
Boohoo gets ISS backing amid Frasers Group spat	Dec. 09	AN
GSK's Lung Disease Treatment Application Accepted for Review in US	Dec. 09	MT
GSK's Application for Blenrep Combination Therapy Accepted in China for Priority Review	Dec. 09	MT
GSK plc Announces Blenrep Combination China Filing Acceptance	Dec. 09	CI
Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement	Dec. 09	MT
GSK : Deutsche Bank is Neutral	Dec. 06	ZD
Glaxosmithkline in collaboration with Muna Therapeutics on Alzheimer's disease	Dec. 06	FW
Global markets live: Walt Disney, Eli Lilly, Microsoft, GSK, Shell...	Dec. 05
GSK : Goldman Sachs is Neutral	Dec. 05	ZD
GSK: revises agreement with Zhifei for Shingrix in China	Dec. 05	CF
GSK expands Chinese shingles vaccine collaboration with Zhifei	Dec. 05	AN
GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034	Dec. 05	DJ

GSK plc is a global biopharma company. The Companyâs segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Employees

70,212

Sector

Pharmaceuticals

Calendar

11:00am - American Society of Hematology Meeting

More about the company